Correlation Between Viridian Therapeutics and LianBio ADR
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and LianBio ADR at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and LianBio ADR into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and LianBio ADR, you can compare the effects of market volatilities on Viridian Therapeutics and LianBio ADR and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of LianBio ADR. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and LianBio ADR.
Diversification Opportunities for Viridian Therapeutics and LianBio ADR
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Viridian and LianBio is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and LianBio ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LianBio ADR and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with LianBio ADR. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LianBio ADR has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and LianBio ADR go up and down completely randomly.
Pair Corralation between Viridian Therapeutics and LianBio ADR
If you would invest 218.00 in LianBio ADR on August 25, 2024 and sell it today you would earn a total of 0.00 from holding LianBio ADR or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 2.22% |
| Values | Daily Returns |
Viridian Therapeutics vs. LianBio ADR
Performance |
| Timeline |
| Viridian Therapeutics |
| LianBio ADR |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Viridian Therapeutics and LianBio ADR Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viridian Therapeutics and LianBio ADR
The main advantage of trading using opposite Viridian Therapeutics and LianBio ADR positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, LianBio ADR can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LianBio ADR will offset losses from the drop in LianBio ADR's long position.| Viridian Therapeutics vs. Eliem Therapeutics | Viridian Therapeutics vs. HCW Biologics | Viridian Therapeutics vs. Scpharmaceuticals | Viridian Therapeutics vs. Milestone Pharmaceuticals |
| LianBio ADR vs. Sensei Biotherapeutics | LianBio ADR vs. NextCure | LianBio ADR vs. Nuvation Bio | LianBio ADR vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |